Biolux Research Raises $14M in Series A Round led by Venrock; Appoints David Thrower as Chief Executive Officer VANCOUVER, Canada, April 30, 2019-- Biolux Research announced the close of a $14M Series A round led by Venrock and joined by Correlation Ventures, insiders and other investors. Coincident with the completion of the round, Biolux announced that David Thrower has been appointed Chief Executive Officer of the company. Biolux manufactures OrthoPulse®, an FDA cleared orthodontic device currently being sold in the United States, Europe, and Asia.